Deep Track Capital »

Pepgen shares owned by Deep Track Capital

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.5M 1.2M 4.62

More positions owned by Deep Track Capital

Guardant Health (GH)
Ionis Pharmaceuticals (IONS)
Cytokinetics Com New (CYTK)
Akero Therapeutics (AKRO)
Apellis Pharmaceuticals (APLS)
Tarsus Pharmaceuticals (TARS)
Immunovant (IMVT)
Dynavax Technologies Corp Com New (DVAX)
Ocular Therapeutix (OCUL)
89bio (ETNB)
Structure Therapeutics Sponsored Ads (GPCR)
Miragen Therapeutics (VRDN)
Protagonist Therapeutics (PTGX)
Axsome Therapeutics (AXSM)
Vaxcyte (PCVX)

View all positions for Deep Track Capital

Top funds holding Pepgen

RA Capital Management
Viking Global Investors
Commodore Capital
Vivo Capital
Point72 Asset Management
BVF
Laurion Capital Management
Vanguard Group
Henderson Group
Rtw Investments
Adage Capital Partners GP
Balyasny Asset Management
Woodline Partners
Deep Track Capital
TCG Crossover Management

View all funds holding Pepgen